Neutrogena Rapid Clear Stubborn Daily Leave On Mask
Loading...Neutrogena Rapid Clear Stubborn Daily Leave On Mask Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
For external use only.
When using this product- Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
- Have very sensitive skin.
- Are sensitive to benzoyl peroxide.
- Avoid unnecessary sun exposure and use a sunscreen.
- Avoid contact with the eyes, lips and mouth.
- Avoid contact with hair or dyed fabrics, which may be bleached by this product.
- Skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.
- Irritation becomes severe.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Do not use if you- Have very sensitive skin.
- Are sensitive to benzoyl peroxide.
- Irritation becomes severe.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
For the treatment of acne.
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Neutrogena Rapid Clear Stubborn Daily Leave On Mask Manufacturers
-
Johnson & Johnson Consumer Inc.
![Neutrogena Rapid Clear Stubborn Daily Leave On Mask (Benzoyl Peroxide) Gel [Johnson & Johnson Consumer Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Neutrogena Rapid Clear Stubborn Daily Leave On Mask | Par Pharmaceutical, Inc.
(See WARNINGS and PRECAUTIONS.)
Dosage should be adjusted according to the indication for therapy, severity of symptoms and the response of the patient.
Geriatric PatientsDose adjustment such as reducing the total dose administered at each dosing or increasing the dosing interval should be considered in elderly patients with renal impairment (creatinine clearance ≤ 70 mL/min/1.73m2). Final dose adjustment should be based upon integration of clinical efficacy and safety considerations. (See CLINICAL PHARMACOLOGY and PRECAUTIONS).
Patients with Renal ImpairmentIn subjects with renal impairment (creatinine clearance ≤ 70 mL/min/1.73m2), dose adjustment such as reducing the total dose administered at each dosing or increasing the dosing interval should be considered. (See CLINICAL PHARMACOLOGY and DOSAGE AND ADMINISTRATION).
INJECTABLE, 100 mg/mL (Not for use in pediatric patients)
Usual Adult Dosage
2 mL (200 mg) t.i.d. or q.i.d. intramuscularly.NOTE: The injectable form is intended for intramuscular administration only; it is not recommended for intravenous use.
Intramuscular administration may cause pain, stinging, burning, redness and swelling at the site of injection. Such effects may be minimized by deep injection into the upper outer quadrant of the gluteal region, and by avoiding the escape of solution along the route.
Login To Your Free Account